SPHRF News Alert Starpharma Holdings (SPHRF) 0.6622 09/20/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Starpharma Holdings (SPHRF) 0.6622 $SPHRF

FDA Grants Special Protocol Assessment (SPA) Agreement for Starpharma Phase 3 Recurrent BV Trial
Business Wire - Mon Jul 14, 4:35AM CDT
Starpharma Holdings Ltd (ASX:SPL) (OTCQX:SPHRY) today announced that the US Food and Drug Administration (FDA) has granted Special Protocol Assessment (SPA) agreement on the design and planned analyses of the phase 3 clinical studies of the VivaGel(R) bacterial vaginosis (BV) product for the prevention of recurrent BV.

New IGP Sets His Priorities, Warns Unethical Officers
by Abdulwakil Saiboko - All Africa Global Media - Thu Jan 09, 10:36PM CST
THE newly-appointed Inspector- General of Police (IGP), Mr Ernest Mangu, has outlined his priorities, warning police over unethical behaviour, saying severe measures will be taken against violators.

The Ellen's Corkrum Recordings and Its Legal Implication [opinion]
by Dashward A. Wumah - All Africa Global Media - Fri Dec 20, 6:34AM CST
In the wake of Ellen Corkrum, former head of the Liberia Airport Authority, and her fiance Melvin Johnson, secret recordings of Musa Bility former Chairman of the Board of Directors of the Liberia Airport Authority (LAA), along with others accused by the Government of Liberia for Economic Sabotage in the tune of over US$1 million. (All Africa 2013), the secret recordings of Defense Minister, Brownie Samukai, and Mr. Chris Massaquoi, the Inspector General of the Liberia National Police

Genital Herpes - Pipeline Review, H2 2013 Reviews Key Players Involved In the Therapeutic Development for Genital Herpes
M2 - Tue Sep 03, 4:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/r3z3pp/genital_herpes) has announced the addition of the "Genital Herpes - Pipeline Review, H2 2013" report to their offering. Global Markets Direct's, 'Genital Herpes - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Genital Herpes, complete with latest updates, and special features on late-stage and discontinued projects. Genital Herpes - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - A snapshot of the global therapeutic scenario for Genital Herpes. - A review of the Genital Herpes products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Genital Herpes pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Companies Mentioned: - AiCuris GmbH & Co. KG - Antigenics, Inc. - Flamel Technologies S.A. - Foamix Ltd. - NanoViricides, Inc. - Profectus BioSciences, Inc. - Starpharma Holdings Limited - Wittycell S.A.S. For more information visit http://www.researchandmarkets.com/research/r3...tal_herpes About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Starpharma and Makhteshim Agan in Priostar Agrochemical Collaboration
PR Newswire - Wed Mar 13, 3:02AM CDT
Starpharma Holdings Ltd (ASX:SPL; OTCQX: SPHRY) and Makhteshim Agan Group today announced a collaboration program. This will see Starpharma's Priostar® dendrimer technology applied to novel crop protection formulations across Makhteshim Agan's extensive product portfolio.

Herpes Simplex Virus Treatment - Global Strategic Business Report
M2 - Thu Feb 14, 6:13AM CST
Research and Markets (http://www.researchandmarkets.com/research/3fnf3m/herpes_simplex) has announced the addition of the "Herpes Simplex Virus Treatment - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Herpes Simplex Virus Treatment in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain. Key Topics Covered I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Treatment Of Herpes Simplex Virus Infection 3. Hsv Vaccines - An Insight 4. Herpes Simplex Virus Infection - The Disease, Causes, Symptoms, And Diagnosis 5. Pipeline Analysis 6. Product Launche




Scroll down for more posts ▼

Top 10 Most Recent News Articles

CASEKOO's Montana Story Makes Brand Purpose Personal

Updated Category News Views 45

A blurry Montana kitchen, not a glossy product render, is doing the heavy lifting for CASEKOO this Thanksgiving. That is either a smart bit of brand discipline or a sentimental detour, depending on whether the company can make people feel something without losing sight of why they bought a phone case in the first place. Warmth Takes the Place of Hardware CASEKOO's new...

Continue Reading
Epiroc Takes Live Remote Drilling to CES 2027 Stage

Updated Category News Views 48

A drill rig chewing through Virginia rock from a Las Vegas convention booth is either a serious industrial-tech moment or an expensive magic trick. At CES 2027, Epiroc intends to make the distinction painfully clear. From January 6 through 9, the Stockholm-based mining-equipment company and Luck Stone will connect Booth 7031 in the LVCC West Hall to a working quarry in...

Continue Reading
Fire-Resistant Lubricants Offer a Quiet Value Shift

Updated Category News Views 67

Hydraulic fluid is not the sort of product that gets anyone pounding the table, and that is precisely why this little industrial pocket deserves a hard look. The fire-resistant lubricants market is estimated at $2.35 billion in 2026 and projected to reach $2.83 billion by 2031, implying a 3.74% compound annual growth rate. That is not a rocket ship. It is a slow-moving,...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 53

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
Foresight Solar Insurance Trial Beats Fixed PPA Route

Updated Category News Views 107

Six solar sites and one settled insurance contract have produced a result worth studying, not celebrating with confetti. Foresight and Paratus say their completed renewable-price insurance policy generated a £14.49/MWh net uplift, after premium, against the revenue those assets would have earned under a fixed-price power purchase agreement. In a UK renewables market...

Continue Reading
CITGO Sign Return Caps Kenmore's Careful Rebuild Work

Updated Category News Views 62

Thirty feet upward and 120 feet eastward is not the sort of move that usually stops a city in its tracks, yet Boston’s CITGO Sign was never merely rooftop hardware. Its public relighting in Kenmore Square marks the final phase of the redevelopment at 660 Beacon Street, and the real accomplishment is less flashy than the lights: a beloved, federally landmarked object...

Continue Reading
COFE+ Barista Test Puts Robotic Coffee on the Clock

Updated Category News Views 84

A swan latte taking 18 seconds less is not nothing, even if it is hardly a verdict on the future of coffee. COFE+, the seventh-generation robotic barista from Shanghai Hi-Dolphin Robot Technology, beat an award-winning human barista across five drinks at a live November 14 competition in Yiwu. That is a clean, visible demonstration of what machines are increasingly built...

Continue Reading
Automus and Google Cloud Put Agents to Work on Oracle

Updated Category News Views 96

Oracle back offices are where shiny AI promises go to earn their keep, or get buried under a mountain of integrations. Automus Consulting’s newly announced collaboration with Google Cloud, unveiled November 20 at Oracle AI World, is aimed squarely at that messy middle. The firm wants to combine its Oracle implementation experience with Google Cloud infrastructure and...

Continue Reading
CVS Puts Youth Soccer Stories on Its Store Shelves

Updated Category News Views 76

Two kids with real community ties just got a megaphone most grown-ups never receive. CVS Pharmacy has named Caroline, 9, of Holmes Beach, Florida, and Zoe, 12, of Los Angeles, as the first grand-prize winners of its Home Team Heroes youth soccer contest. Each player’s selected nonprofit soccer organization will receive a $25,000 grant, while their stories will appear on...

Continue Reading
Highmark’s 2026 Rebound Has a Few Asterisks Attached

Updated Category News Views 35

The Headline Needs a Pencil, Not a Highlighter A $1.9 billion net-income figure can look downright thunderous until you separate the cash-generating engine from the accounting cargo strapped to it. Highmark Health reported $26.5 billion in revenue and $741 million in operating income for the nine months ended Sept. 30, 2026. Those are materially better numbers than the...

Continue Reading

Top 5 Most Recently Viewed Articles

Synetos Aerospace Partners with AFWERX for AI Flight System

Updated Category News Views 202

Synetos Aerospace made waves back when it teamed up with AFWERX to develop an AI-enabled flight augmentation system aimed at improving the safety and efficiency of uncrewed aircraft. This partnership was not just about spiffing up tech; it showcased a commitment to enhancing operational productivity while lightening the load for operators in the increasingly fast-paced...

Continue Reading
Haruhiko Kuroda Takes on New Role at Economic Research Center

Updated Category News Views 256

Haruhiko Kuroda's New Chapter in Economic Research Former Bank of Japan Governor Haruhiko Kuroda is set to begin an exciting new role as an adviser at the Japan Center for Economic Research starting in January. This significant change comes on the heels of his long and impactful tenure at the Bank of Japan, where he served for a decade, shaping the nation's monetary...

Continue Reading
APA Corporation Discusses Key Insights for Q3 2025 Results

Updated Category News Views 269

Insights into APA Corporation's Third-Quarter 2025 APA Corporation (NASDAQ: APA) has shared important details about its projected financial and operational outcomes for the third quarter of 2025. This information aims to guide investors and analysts in their own assessments, focusing on factors expected to influence the company's performance. Estimated Average Realized...

Continue Reading
FibroGen's Strategic Move with AstraZeneca Approved Sale

Updated Category News Views 145

FibroGen Secures Approval for Strategic Sale FibroGen, Inc. (NASDAQ: FGEN), based in San Francisco, has officially received approval from the China State Administration for Market Regulation for the sale of FibroGen International (Hong Kong) Ltd. to AstraZeneca Treasury Limited. This key decision marks a significant milestone as the company moves forward with its plans...

Continue Reading
Curaleaf Secures $100 Million Credit Deal to Boost Growth

Updated Category News Views 146

Curaleaf Expands Credit Facilities to Fuel Business Growth Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF), a prominent player in the cannabis sector, has made headlines by upscaling its revolving credit facility to a whopping $100 million with Needham Bank. This move marks a pivotal moment in the cannabis financing landscape. A Landmark Financing Achievement Boris...

Continue Reading